Applied UV to Present and Showcase Airocide and Scientific Air Technology at Hotel, Restaurant & Catering 2022 in London Medical Device Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Now Available Over the Counter, LASTACAFT® Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours Pharmaceutical Investing
Goodness Growth Holdings to Participate in Minnesota Cannabis Symposium for Healthcare Providers Psychedelics Investing
ALR Technologies Announces Completion of Pivotal Non-Inferiority Study on the GluCurve Pet CGM Medical Device Investing
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19 Pharmaceutical Investing
Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development Psychedelics Investing
Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022 Pharmaceutical Investing
Merck Announces KEYLYNK-010 Trial Evaluating KEYTRUDA® in Combination with LYNPARZA® in Patients with Metastatic Castration-Resistant Prostate Cancer to Stop for Futility Life Science Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
